NO175148C - Fremgangsmåte for fremstilling av et indomethacinsalt av et toverdig metall valgt fra kobber, sink, kobolt og nikkel - Google Patents

Fremgangsmåte for fremstilling av et indomethacinsalt av et toverdig metall valgt fra kobber, sink, kobolt og nikkel

Info

Publication number
NO175148C
NO175148C NO914565A NO914565A NO175148C NO 175148 C NO175148 C NO 175148C NO 914565 A NO914565 A NO 914565A NO 914565 A NO914565 A NO 914565A NO 175148 C NO175148 C NO 175148C
Authority
NO
Norway
Prior art keywords
indomethacin
salt
forming
solution
cobalt
Prior art date
Application number
NO914565A
Other languages
English (en)
Other versions
NO914565L (no
NO175148B (no
NO914565D0 (no
Inventor
Hubertus Leonardus Regtop
John Raymond Biffin
Original Assignee
Biochemical Veterinary Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemical Veterinary Res filed Critical Biochemical Veterinary Res
Publication of NO914565D0 publication Critical patent/NO914565D0/no
Publication of NO914565L publication Critical patent/NO914565L/no
Publication of NO175148B publication Critical patent/NO175148B/no
Publication of NO175148C publication Critical patent/NO175148C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Dental Preparations (AREA)
NO914565A 1989-05-22 1991-11-21 Fremgangsmåte for fremstilling av et indomethacinsalt av et toverdig metall valgt fra kobber, sink, kobolt og nikkel NO175148C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ432889 1989-05-22
PCT/AU1990/000209 WO1990014337A1 (en) 1989-05-22 1990-05-21 Divalent metal salts of indomethacin

Publications (4)

Publication Number Publication Date
NO914565D0 NO914565D0 (no) 1991-11-21
NO914565L NO914565L (no) 1992-01-21
NO175148B NO175148B (no) 1994-05-30
NO175148C true NO175148C (no) 1994-09-07

Family

ID=3773930

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914565A NO175148C (no) 1989-05-22 1991-11-21 Fremgangsmåte for fremstilling av et indomethacinsalt av et toverdig metall valgt fra kobber, sink, kobolt og nikkel

Country Status (12)

Country Link
US (1) US5310936A (no)
EP (1) EP0473655B1 (no)
KR (1) KR0156231B1 (no)
AT (1) ATE147731T1 (no)
CA (1) CA2058754C (no)
DE (1) DE69029732T2 (no)
DK (1) DK0473655T3 (no)
ES (1) ES2098264T3 (no)
IE (1) IE81142B1 (no)
NO (1) NO175148C (no)
NZ (1) NZ233776A (no)
WO (1) WO1990014337A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466824A (en) * 1989-05-22 1995-11-14 Biochemical Veterinary Research Pty. Ltd. Divalent metal complexes of indomethacin, compositions and medical methods of use thereof
FR2758819B1 (fr) * 1997-01-29 2000-01-21 Laprophan Laboratoires Pharma Indometacine calcique et sa preparation
US7045531B1 (en) 1997-03-11 2006-05-16 The General Hospital Corporation Composition comprising a metal chelator and a method of treating amyloidosis by administering the metal chelator
US20050112543A1 (en) * 1998-03-11 2005-05-26 The General Hospital Corporation Method of screening for drugs useful in treating Alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
JP2007530599A (ja) * 2004-03-30 2007-11-01 メディカル セラピーズ リミテッド 金属イオンとカルボキシレート配位子とを含む坑炎症活性を有する錯体を含有する組成物
WO2007026240A1 (en) * 2005-09-01 2007-03-08 Medical Therapies Limited Sunscreen and cosmetic compositions for prophylaxis or treatment of skin cancers
HU227696B1 (en) * 2006-04-13 2011-12-28 Egyt Gyogyszervegyeszeti Gyar Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it
US11000533B2 (en) * 2011-03-25 2021-05-11 Trackside Technologies Pty Ltd. Connective tissue monitoring, compositions for connective tissue treatment and methods for treating connective tissue
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US8912226B2 (en) 2012-05-18 2014-12-16 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR
US9308196B2 (en) 2012-05-18 2016-04-12 Gruenenthal Gmbh Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669987A (en) * 1967-04-11 1972-06-13 Sumitomo Chemical Co Salts of indole derivatives and a process for preparing the same
DK244179A (da) * 1978-06-13 1979-12-14 Merck & Co Inc Fremgangsmaade til fremstilling af krystallinsk natrium og kaliumindomethacin og trihydrater deraf
JPH06104624B2 (ja) * 1986-05-07 1994-12-21 太郎 小木曽 経皮吸収剤
EP0405602A1 (en) * 1989-06-30 1991-01-02 Laboratorios Vinas S.A. New Zinc derivatives of anti-inflammatory drugs having improved therapeutic activity

Also Published As

Publication number Publication date
KR920700639A (ko) 1992-08-10
ES2098264T3 (es) 1997-05-01
DE69029732D1 (de) 1997-02-27
IE901831L (en) 1990-11-22
EP0473655A4 (en) 1992-05-20
NO914565L (no) 1992-01-21
DE69029732T2 (de) 1997-05-07
DK0473655T3 (da) 1997-02-10
NO175148B (no) 1994-05-30
ATE147731T1 (de) 1997-02-15
CA2058754A1 (en) 1990-11-23
EP0473655A1 (en) 1992-03-11
NO914565D0 (no) 1991-11-21
KR0156231B1 (ko) 1998-11-16
CA2058754C (en) 2002-02-19
NZ233776A (en) 1991-09-25
WO1990014337A1 (en) 1990-11-29
EP0473655B1 (en) 1997-01-15
IE81142B1 (en) 2000-04-19
US5310936A (en) 1994-05-10

Similar Documents

Publication Publication Date Title
NO175148C (no) Fremgangsmåte for fremstilling av et indomethacinsalt av et toverdig metall valgt fra kobber, sink, kobolt og nikkel
US20190160081A1 (en) Boron containing small molecules as anti-inflammatory agents
Vodanovic-Jankovic et al. NF-κB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145
IL110492A0 (en) (di(ether or thioether) heteroaryl or fluoro substituted aryl) compounds, their preparation and pharmaceutical compositions containing them
RU95108231A (ru) Glp-1-молекулярный комплекс, фармацевтическая композиция и способ получения комплекса
UA49787C2 (uk) Спосіб підвищення цитотоксичності хіміотерапевтичного агента та спосіб підвищення цитотоксичності днк-алкілувального хіміотерапевтичного агента
RU94046411A (ru) Производные витамина д, способ их получения, фармацевтическая композиция на их основе и способ ее получения, способ лечения
SU1342417A3 (ru) Cпocoб пoлучehия пpoизboдhыx 2-amиho-5-okcи-4-metилпиpиmидиha или иx kиcлotho-aддиtиbhыx coлeй
ES8601965A1 (es) Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona
US4929739A (en) Complexes of tellurium and selenium derivatives
AU613890B2 (en) 4-thiazolidinecarboxylic acid derivative, its preparation and pharmaceutical compositions containing it
NZ228275A (en) Indoloquinolines and benzo (b) and (c) acridines
JPH01287022A (ja) 抗癌剤耐性克服剤
Wang et al. In vitro and in vivo growth inhibition of cancer cells by adamantylmaleimide derivatives
CA1327047C (en) Complexes of tellurium and selenium derivatives
EP0372676A1 (en) Therapeutic preparation and method
KR930702984A (ko) 비-소세포 폐암의 치료
JPS6456615A (en) Remedy for nephropathy
NZ308024A (en) The reaction product of alkaloids of Chelidonium maius L. with thiophosphoric acid triaziridide is used as radiation treatment medicine
SU606242A1 (ru) Антилепрозное средство "димоцифон"
Farahmandian et al. A PRELIMINARY TRIAL OF THE MASS-TREATMENT OF URINARY BILHARZIASIS WITH AN ORGANO-PHOSPHORUS COMPOUND
JPS5791914A (en) Peptic unti-ulcer
JPS60184018A (ja) 抗原虫剤
Fishbain " Priapism and neuroleptics: A case report": Comment.
JPS57109722A (en) Antitumor agent containing deoxyfluorouridine benzyloxylated at 4-position